Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Poon MC, d'Oiron R, Hann I, Négrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marquès-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G. Poon MC, et al. Among authors: fressinaud e. Semin Hematol. 2001 Oct;38(4 Suppl 12):21-5. doi: 10.1016/s0037-1963(01)90143-x. Semin Hematol. 2001. PMID: 11735106 Review.
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
Rothschild C, Laurian Y, Satre EP, Borel Derlon A, Chambost H, Moreau P, Goudemand J, Parquet A, Peynet J, Vicariot M, Beurrier P, Claeyssens S, Durin A, Faradji A, Fressinaud E, Gaillard S, Guérin V, Guérois C, Pernod G, Pouzol P, Schved JF, Gazengel C. Rothschild C, et al. Among authors: fressinaud e. Thromb Haemost. 1998 Nov;80(5):779-83. Thromb Haemost. 1998. PMID: 9843171
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I, Kriaa F, Proulle V, Guillet B, Kaplan C, D'Oiron R, Debré M, Fressinaud E, Laurian Y, Tchernia G, Charpentier B, Lambert T, Dreyfus M. Martin I, et al. Among authors: fressinaud e. Br J Haematol. 2002 Dec;119(4):991-7. doi: 10.1046/j.1365-2141.2002.03936.x. Br J Haematol. 2002. PMID: 12472579 Free article.
First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene.
Hilbert L, D'Oiron R, Fressinaud E, Meyer D, Mazurier C; INSERM Network on Molecular Abnormalities in von Willebrand Disease. Hilbert L, et al. Among authors: fressinaud e. J Thromb Haemost. 2004 Dec;2(12):2271-3. doi: 10.1111/j.1538-7836.2004.01049.x. J Thromb Haemost. 2004. PMID: 15613050 Free article. No abstract available.
Long-term survival of HIV-infected patients with haemophilia.
Stieltjes N, Sultan Y, Rothschild C, Torchet MF, Laurian Y, Navarro R, Fressinaud E, Gernez AP, Fonlupt J, Berthier AM. Stieltjes N, et al. Among authors: fressinaud e. Haemophilia. 1995 Jan;1(1):33-6. doi: 10.1111/j.1365-2516.1995.tb00037.x. Haemophilia. 1995. PMID: 27214219
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.
Saultier P, Guillaume Y, Demiguel V, Berger C, Borel-Derlon A, Claeyssens S, Harroche A, Oudot C, Rafowicz A, Trossaert M, Wibaut B, Vinciguerra C, Boucekine M, Baumstarck K, Meunier S, Calvez T, Chambost H; FranceCoag PUPs / CoMETH Prophylaxis Study Group; Hemophilia Treatment Centers of Paris-Necker. Saultier P, et al. J Pediatr. 2021 Jul;234:212-219.e3. doi: 10.1016/j.jpeds.2021.02.071. Epub 2021 Mar 4. J Pediatr. 2021. PMID: 33676933 Clinical Trial.
103 results